TH
Telegraph Hill
San Francisco, California, United StatesFounded 2001
Telegraph Hill Partners is a venture capital firm that focuses on providing growth capital and strategic guidance to private life science, medical device, and healthcare companies. Their strategy involves partnering with companies that possess novel technologies, a solid customer base, and innovative management teams to help them achieve their growth objectives.
40% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (40% of deals). Average disclosed round size is $12.9M (across 4 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Kytopen Corp. | Series B | — | Apr 2026 |
 Artemis | Pre-Seed | $1.5M | May 2024 |
 UnDosTres | Series B | $30M | Jul 2022 |
| NNivagen Pharmaceuticals | Growth | $16M | May 2020 |
| FFleet | Seed | $4M | Apr 2016 |
Top Co-Investors
Last updated: 9 April 2026